[1]
Ali, A.J. et al. 2026. Cardiovascular Benefits and Pharmacological Mechanisms of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Narrative Review. Indus Journal of Bioscience Research. 4, 2 (Feb. 2026), 47–57. DOI:https://doi.org/10.70749/ijbr.v4i2.2909.